In detail, the underlying pathophysiology about BBB impairment in stroke such as protein phosphorylation, breakdown of tight junction proteins, lytic cellular death upon BBB, and supporting structures as well as neutrophils and lymphocytes transcytosis, all can be reversed by selective caspase-1 inhibition in some extent. The gene discussed is CASP1; the disease is Stroke.